6Gallus AS,Baker RI,Chong BH,et al.Consensus guidelines for warfarin therapy.Recommendation from the Australasian Society of Thrombosis and Heamostasis[J].Med J Aust,2000,172(12):600-605.
3Hoblas FD,Fitzmaurice DA,Mant J,et al.A randomized controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over.The SAFE Study.Health Technol Assess,2005,9:1-90.
5Hylek EM,GO AS,Chang Y,et al.Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.Nengl J Med,2003,349:1019-1026.
6Hart RG,Benavente O,McBride R,et al.Antithrombotic therapy to prevent stroke in patients with atrial fibrillation:a metaanalysis.Ann Intern Med,1999,131:492-501.
7Mant J,Hobbs FDR,Fletcher K,et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (The Birmingham Atrial Fibrillation Treatment of the Aged Study,BAFTA):a randomized controlled trial.Lancet,2007,370:493-503.
8Hylek EM,D Antonio J,Evans-Mol.ina C,et al.Translating the results of randomized trials into clinical practice:the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.Stroke,2006,37:1075-1080.
9Guo YT,Wu Q,Zhang L,et al.Antithrombotic therapy in very Elderly patients with atrial fibrillation:Is it enough to assess thrombo-embolic risk? Clinical Interventions in Aging,2010,5:157-162.
10Atrial Fibrillation Investigator,risk gactors for stroke and efficacy of antithrombotic therapy for atrial fibrillation:analysis of pooled data from five randomized controlled trials.Arch Intern Med,1994,154:1449-1457.
